Table 3.
Total complications per patient demographics
| Complications n (%) | Without complications n (%) | P-value | |
|---|---|---|---|
| Age, years | |||
| ≥75 | 40 (10.13) | 207 (52.41) | 0.5935 |
| <75 | 21 (5.32) | 127 (32.15) | |
| Sex | |||
| Male | 18 (4.48) | 117 (29.10) | 0.4095 |
| Female | 44 (10.95) | 223 (55.47) | |
| INR goal | |||
| 2.5 | 53 (13.12) | 306 (75.74) | 0.358 |
| 3 | 9 (2.23) | 36 (8.91) | |
| Insurance type | |||
| Medicare | 14 (3.47) | 129 (31.93) | 0.0474 |
| Medicare/private | 12 (2.97) | 34 (8.42) | |
| Private | 5 (1.24) | 34 (8.42) | |
| Unknown | 31 (7.67) | 150 (37.13) | |
| Indication to treat | |||
| Afib/Aflutter | 43 (10.64) | 191 (47.28) | 0.0282 |
| DVT/PE | 8 (1.98) | 107 (26.49) | |
| MVR/AVR | 9 (2.23) | 33 (8.17) | |
| Other | 2 (0.50) | 11 (2.72) | |
| Comorbidities | |||
| 0–2 | 11 (2.74) | 105 (26.12) | 0.0550 |
| 3–4 | 20 (4.98) | 117 (29.10) | |
| >4 | 30 (7.46) | 119 (29.60) | |
| Medications | |||
| 0–4 | 10 (2.48) | 124 (30.69) | 0.0081 |
| 5–7 | 26 (6.44) | 112 (27.72) | |
| >7 | 26 (6.44) | 106 (26.24) | |
| Herbals | |||
| 0 | 30 (7.46) | 221 (54.98) | 0.0130 |
| ≥1 | 32 (7.96) | 119 (29.60) | |
Abbreviations: n, number; INR, international normalized ratio; Afib/Aflutter, atrial fibrillation/flutter; DVT/PE, deep vein thrombosis/pulmonary embolism; MVR/AVR, mitral/aortic valve replacement.